Stock Price Quote

BETA DRUGS LTD.

NSE : NABSE : ISIN CODE : INE351Y01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 21-09 2005
Management Info
Rahul Batra - Chairman Rahul Batra - Managing Director
Registered Office

Address Village Nandpur,Lodhimajra Road,Distt Solan,
Baddi,
Himachal Pradesh-174101

Phone 01795-236196

Email cs@betadrugslimited.com

Website www.betadrugslimited.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : NSE

NEWS

08Jan General Announcement
Beta Drugs Limited has informed the Exchange about Certificate under SEB..
07Dec Updates
Beta Drugs Limited has informed the Exchange regarding 'Beta Drugs Limit..
29Nov Updates
Beta Drugs Limited has informed the Exchange regarding 'Beta Drugs Limit..
24Nov Updates
Beta Drugs Limited has informed the Exchange regarding 'Beta Drugs Limit..
29Sep Beta Drugs coming with an IPO to raise
Beta DrugsBeta Drugs is coming out with an initial public offering (IPO)..

Financials

in Millions
QTR ANNUAL 23
Net Profit188.15
Gross Profit 252.09
Operating Profit 322.41
Net Sales 1578.75

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Pfizer (BSE)
peergroup  4569.90 (4.30%)
M.Cap ( in Cr)20906.26
Neuland Laboratories (BSE)
peergroup  7102.20 (0.54%)
M.Cap ( in Cr)9112.04
Bajaj Healthcare (BSE)
peergroup  356.30 (11.20%)
M.Cap ( in Cr)983.33
Caplin Point Lab (BSE)
peergroup  1452.35 (1.89%)
M.Cap ( in Cr)11029.40
Jenburkt Pharma (BSE)
peergroup  787.20 (3.23%)
M.Cap ( in Cr)347.41

Shareholding Pattern

PROMOTERS 66.73%
NON-INSTITUTION 32.94%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Beta Drugs Ltd.

Beta Drugs Ltd. was incorporated in the year 2005. Its today's share price is 0. Its current market capitalisation stands at Rs 1212.78 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1578.75 Cr and Total Income of Rs.1589.17 Cr. The company's management includes Rajni Brar, Manmohan Khanna, Rohit Parti, Ashutosh Shukla, Seema Chopra, Balwant Singh, Varun Batra, Rahul Batra, Rahul Batra.

It is listed on the BSE with a BSE Code of  , NSE with an NSE Symbol of BETA and ISIN of INE351Y01019. It's Registered office is at Village Nandpur,Lodhimajra Road,Distt SolanBaddi-174101, Himachal Pradesh. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Kalra Rai & Asociates, Kalra Rai & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.